| 1 | English French Notes Complete/Exclude
|
|---|
| 2 | 23. NUMBER OF TUMORS
|
|---|
| 3 | 24. DATE OF FIRST SYMPTOMS
|
|---|
| 4 | 25. DATE OF INITIAL DIAGNOSIS
|
|---|
| 5 | 26. DATE OF PATHOLOGIC DIAGNOSIS
|
|---|
| 6 | 27. PRIMARY SITE (ICD-O-2)
|
|---|
| 7 | 28. WHO HISTOLOGICAL CLASSIFICATION OF TUMOR
|
|---|
| 8 | 29. BEHAVIOR CODE (ICD-O-2)
|
|---|
| 9 | 31. DIAGNOSTIC CONFIRMATION
|
|---|
| 10 | 32. MOLECULAR MARKERS
|
|---|
| 11 | 33. TUMOR SIZE
|
|---|
| 12 | 34. TUMOR SIZE (SOURCE
|
|---|
| 13 | 35. KARNOFSKY'S RATING PRIOR TO THERAPY
|
|---|
| 14 | 34. TUMOR SIZE (SOURCE)
|
|---|
| 15 | 17. CLASS OF CASE.................:
|
|---|
| 16 | 1222 CHANGE IN SENSE OF SMELL AND/ OR TASTE....................
|
|---|
| 17 | 1223 ALTERED ALERTNESS............
|
|---|
| 18 | 1225 SPEECH DISTURBANCE...........
|
|---|
| 19 | 1226 PERSONALITY CHANGES..........
|
|---|
| 20 | 1228 MEMORY LOSS..................
|
|---|
| 21 | 1229 LACK OF CONCENTRATION........
|
|---|
| 22 | 1230 DOUBLE VISION................
|
|---|
| 23 | 1231 OTHER VISUAL DISTURBANCE.....
|
|---|
| 24 | 1232 DECREASED HEARING............
|
|---|
| 25 | 1236 WEAKNESS OR PARALYSIS........
|
|---|
| 26 | 1237 DIFFICULTY IN COORDINATION/ BALANCE.....................
|
|---|
| 27 | 1238 GENERALIZED SEIZURE..........
|
|---|
| 28 | 1239 FOOD SEIZURE.................
|
|---|
| 29 | 1240 BLADDER INCONTINENCE.........
|
|---|
| 30 | 1241 BOWEL INCONTINENCE...........
|
|---|
| 31 | 1242 PAIN (OTHER THAN HEADACHE)...
|
|---|
| 32 | 1243 WEIGHT CHANGE................
|
|---|
| 33 | 19. NEUROLOGICAL FINDINGS:
|
|---|
| 34 | 1248 MEMORY OR JUDGEMENT..........
|
|---|
| 35 | 1249 VISUAL ACUITY................
|
|---|
| 36 | 1250 VISUAL FIELDS................
|
|---|
| 37 | 1251 EYE MOVEMENTS (EOM)..........
|
|---|
| 38 | 1252 FACIAL SENSATION.............
|
|---|
| 39 | 1253 FACIAL MOVEMENT..............
|
|---|
| 40 | 1255 GAG REFLEX...................
|
|---|
| 41 | 1256 STERNOCLEIDOMASTOID/SHOULDER SHRUG STRENGTH..............
|
|---|
| 42 | 1257 ARTICULATION OR ENUNCIATION..
|
|---|
| 43 | 1259 TONGUE FASCICULATIONS OR ATROPHY.....................
|
|---|
| 44 | 1260 DECREASE IN SENSATION OF ANY SITE........................
|
|---|
| 45 | 1261 CORTICAL SENSORY DEFICIT.....
|
|---|
| 46 | 1262 WEAKNESS, ATROPHY OR FASCICULATION OF ANY SITE.................
|
|---|
| 47 | 1263 ATAXIA OF GAIT...............
|
|---|
| 48 | 1264 TRUNCAL ATAXIA...............
|
|---|
| 49 | 1266 RAPID ALTERNATING MOVEMENTS..
|
|---|
| 50 | 1267 FINGER TO FINGER NOSE TESTING
|
|---|
| 51 | 1268 HEEL TO KNEE TO SHIN TESTING.
|
|---|
| 52 | 1269 DEEP TENDON REFLEXES IN UPPER EXTREMITIES.................
|
|---|
| 53 | 1270 DEEP TENDON REFLEXES IN LOWER EXTREMITIES.................
|
|---|
| 54 | 1271 BABINSKI SIGN................
|
|---|
| 55 | 1272 HOFFMAN REFLEX...............
|
|---|
| 56 | 1273 OTHER ABNORMAL REFLEXES......
|
|---|
| 57 | 20. PRE-THERAPY DIAGNOSTIC STUDIES:
|
|---|
| 58 | 1275 CT SCAN OF BRAIN.............
|
|---|
| 59 | 1276 CT SCAN OF SPINE.............
|
|---|
| 60 | 1278 ISOTOPE BRAIN SCAN...........
|
|---|
| 61 | 1279 PET SCAN.....................
|
|---|
| 62 | 1280 SPECT SCAN...................
|
|---|
| 63 | 1281 MRI OF BRAIN.................
|
|---|
| 64 | 1282 MRI OF SPINE.................
|
|---|
| 65 | 1283 FUNCTIONAL MRI...............
|
|---|
| 66 | 21. TUMOR LOCATION/INVOLVEMENT:
|
|---|
| 67 | 1286 FRONTAL LOBE.................
|
|---|
| 68 | 1287 TEMPORAL LOBE................
|
|---|
| 69 | 1288 PARIETAL LOBE................
|
|---|
| 70 | 1289 OCCIPITAL LOBE...............
|
|---|
| 71 | 1290 OPTIC NERVES.................
|
|---|
| 72 | 1291 PITUITARY GLAND..............
|
|---|
| 73 | 1292 PINEAL GLAND.................
|
|---|
| 74 | 1294 BRAIN STEM...................
|
|---|
| 75 | 1295 SKULL BASE...................
|
|---|
| 76 | 1296 OTHER SKULL..................
|
|---|
| 77 | 1297 SPINAL CORD..................
|
|---|
| 78 | 1298 CEREBRAL SPINAL FLUID (CSF)..
|
|---|
| 79 | 1299 CRANIAL MENINGES.............
|
|---|
| 80 | 1300 SPINAL MENINGES..............
|
|---|
| 81 | 1305 23. NUMBER OF TUMORS..............
|
|---|
| 82 | 1306 24. DATE OF FIRST SYMPTOMS........
|
|---|
| 83 | 25. DATE OF INITIAL DIAGNOSIS.....:
|
|---|
| 84 | 1307 26. DATE OF PATHOLOGIC DIAGNOSIS..
|
|---|
| 85 | 27. PRIMARY SITE (ICD-O-2)........:
|
|---|
| 86 | 1308 28. WHO HISTOLOGICAL CLASSIFICATION OF TUMOR.....................
|
|---|
| 87 | 29. BEHAVIOR CODE (ICD-O-2).......:
|
|---|
| 88 | 31. DIAGNOSTIC CONFIRMAITON.......:
|
|---|
| 89 | 1309 32. MOLECULAR MARKERS.............
|
|---|
| 90 | 1394 33. TUMOR SIZE....................
|
|---|
| 91 | 34. TUMOR SIZE (SOURCE)...........: Size not recorded
|
|---|
| 92 | 1310 34. TUMOR SIZE (SOURCE)...........
|
|---|
| 93 | 1311 35. KARNOFSKY'S RATING PRIOR TO THERAPY......................
|
|---|
| 94 | 36. PROTOCOL PARTICIPATION
|
|---|
| 95 | 37. PROTOCOL PHASE
|
|---|
| 96 | 38. DATE OF FIRST COURSE TREATMENT
|
|---|
| 97 | 39. DATE OF INPATIENT ADMISSION
|
|---|
| 98 | 40. DATE OF INPATIENT DISCHARGE
|
|---|
| 99 | 41. DATE OF NON CA-DIRECTED SURGERY
|
|---|
| 100 | 42. DIAGNOSTIC/EVALUATIVE/PALLIATIVE (NON CA-DIRECTED) SURGERY
|
|---|
| 101 | 43. DATE OF CA-DIRECTED SURGERY
|
|---|
| 102 | 44. SURGICAL APPROACH
|
|---|
| 103 | 45. EXTENT OF SURGICAL RESECTION
|
|---|
| 104 | 46. SIZE OF RESIDUAL PRIMARY TUMOR FOLLOWING CA-DIRECTED SURGERY
|
|---|
| 105 | 47. SIZE OF RESIDUAL PRIMARY TUMOR FOLLOWING CA-DIRECTED SURGERY (SOURCE)
|
|---|
| 106 | 48. SURGICAL COMPLICATIONS/POST SURGICAL EVENTS
|
|---|
| 107 | 49. REASON FOR NO SURGERY
|
|---|
| 108 | 50. RADIATION THERAPY
|
|---|
| 109 | 51. DATE RADIATION STARTED
|
|---|
| 110 | 52. DATE RADIATION ENDED
|
|---|
| 111 | 53. TOTAL RADIATION DOSE (cGy)
|
|---|
| 112 | 54. NUMBER OF TREATMENTS TO THIS VOLUME
|
|---|
| 113 | 55. TYPE OF EXTERNAL BEAM RADIATION
|
|---|
| 114 | 56. INTERSTITIAL RADIATION/BRACHYTHERAPY
|
|---|
| 115 | 57. STEREOTACTIC RADIOSURGERY
|
|---|
| 116 | 58. RADIATION/SURGERY SEQUENCE
|
|---|
| 117 | 59. RADIATION COMPLICATIONS
|
|---|
| 118 | 60. REASON FOR NO RADIATION
|
|---|
| 119 | 61. DATE CHEMOTHERAPY STARTED
|
|---|
| 120 | 63. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED
|
|---|
| 121 | 64. CHEMOTHERAPEUTIC ROUTE
|
|---|
| 122 | 65. CHEMOTHERAPY COMPLICATIONS
|
|---|
| 123 | 66. REASON FOR NO CHEMOTHERAPY
|
|---|
| 124 | 67. DATE OTHER TREATMENT STARTED
|
|---|
| 125 | 68. OTHER TREATMENT
|
|---|
| 126 | 69. KARNOFSKY'S RATING AT TIME OF DISCHARGE/TRANSFER
|
|---|
| 127 | 1312 36. PROTOCOL PARTICIPATION........
|
|---|
| 128 | 37. PROTOCOL PHASE................: Not on
|
|---|
| 129 | 1313 37. PROTOCOL PHASE................
|
|---|
| 130 | 38. DATE OF FIRST COURSE TREATMENT:
|
|---|
| 131 | 1 39. DATE OF INPATIENT ADMISSION...
|
|---|
| 132 | 1.1 40. DATE OF INPATIENT DISCHARGE...
|
|---|
| 133 | 41. DATE OF NON CA-DIR SURGERY...:
|
|---|
| 134 | 42. DIAGNOSTIC/EVALUATIVE/PALLIATIVE (NON CA-DIRECTED) SURGERY:
|
|---|
| 135 | NONE, NO NON CA-DIRECTED SURGICAL PROCEDURE...: Yes
|
|---|
| 136 | VENTRICULOSTOMY, OR EXTERNAL VENTRICULAR DRAIN: No
|
|---|
| 137 | CSF SHUNT, VENTRICULOPERITONEAL...............: No
|
|---|
| 138 | CSF SHUNT, THIRD VENTRICULOSTOMY..............: No
|
|---|
| 139 | CSF SHUNT, OTHER..............................: No
|
|---|
| 140 | STEREOTACTIC BIOPSY...........................: No
|
|---|
| 141 | OPEN BRAIN BIOPSY.............................: No
|
|---|
| 142 | OPEN BIOPSY OF SPINAL CORD TUMOR..............: No
|
|---|
| 143 | LAMINECTOMY FOR SPINAL CORD TUMOR, W/O TUMOR RESECTION, W/O OPENING DURA........: No
|
|---|
| 144 | UNKNOWN IF SURGERY DONE.......................: No
|
|---|
| 145 | NONE, NO NON CA-DIRECTED SURGICAL PROCEDURE..........: No
|
|---|
| 146 | 1314 NONE, NO NON CA-DIRECTED SURGICAL PROCEDURE..........
|
|---|
| 147 | 1315 VENTRICULOSTOMY, OR EXTERNAL VENTRICULAR DRAIN...........
|
|---|
| 148 | 1316 CSF SHUNT, VENTRICULOPERITONEAL........
|
|---|
| 149 | 1317 CSF SHUNT, THIRD VENTRICULOSTOMY.......
|
|---|
| 150 | 1318 CSF SHUNT, OTHER.......................
|
|---|
| 151 | 1319 STEREOTACTIC BIOPSY..........
|
|---|
| 152 | 1320 OPEN BRAIN BIOPSY............
|
|---|
| 153 | 1321 OPEN BIOPSY OF SPINAL CORD TUMOR.......................
|
|---|
| 154 | 1322 LAMINECTOMY FOR SPINAL CORD TUMOR, W/O TUMOR RESECTION, W/O OPENING DURA...........
|
|---|
| 155 | 1323 LAMINECTOMY FOR SPINAL CORD TUMOR, W/O TUMOR RESECTION, W OPENING DURA.............
|
|---|
| 156 | 1325 UNKNOWN IF SURGERY DONE......
|
|---|
| 157 | 43. DATE OF CA-DIRECTED SURGERY...:
|
|---|
| 158 | 44. SURGICAL APPROACH.............: None, no ca-directed surgery
|
|---|
| 159 | 45. EXTENT OF SURGICAL RESECTION..: None, no surgery performed
|
|---|
| 160 | 46. SIZE OF RESIDUAL PRIMARY TUMOR AFTER CA-DIR SURGERY.........: NA, surgical treatment not administered
|
|---|
| 161 | 47. SIZE OF RESIDUAL PRIMARY TUMOR AFTER CA-DIR SURGERY (SOURCE): Size not recorded
|
|---|
| 162 | 48. SURGICAL COMPLICATIONS/POST SURGICAL EVENTS:
|
|---|
| 163 | ANESTHETIC PROBLEM...........: NA, surgery not performed
|
|---|
| 164 | HEMORRHAGE AT OPERATIVE SITE.: NA, surgery not performed
|
|---|
| 165 | SEIZURE......................: NA, surgery not performed
|
|---|
| 166 | INFECTION(S).................: NA, surgery not performed
|
|---|
| 167 | DVT (DEEP VENOUS THROMBOSIS..: NA, surgery not performed
|
|---|
| 168 | PERSISTENT NEUROLOGICAL WORSENING OVER 4 DAYS POST-OP.........: NA, surgery not performed
|
|---|
| 169 | OTHER........................: NA, surgery not performed
|
|---|
| 170 | 44. SURGICAL APPROACH.............: Surgical approach unknown
|
|---|
| 171 | 45. EXTENT OF SURGICAL RESECTION..: Unknown if surgery performed
|
|---|
| 172 | ANESTHETIC PROBLEM...........: Unknown
|
|---|
| 173 | HEMORRHAGE AT OPERATIVE SITE.: Unknown
|
|---|
| 174 | DVT (DEEP VENOUS THROMBOSIS..: Unknown
|
|---|
| 175 | 1326 44. SURGICAL APPROACH.............
|
|---|
| 176 | 1327 45. EXTENT OF SURGICAL RESECTION..
|
|---|
| 177 | 1328 46. SIZE OF RESIDUAL PRIMARY TUMOR AFTER CA-DIR SURGERY.........
|
|---|
| 178 | 1329 47. SIZE OF RESIDUAL PRIMARY TUMOR AFTER CA-DIR SURGERY (SOURCE)
|
|---|
| 179 | 1330 ANESTHETIC PROBLEM...........
|
|---|
| 180 | 1331 HEMORRHAGE AT OPERATIVE SITE.
|
|---|
| 181 | 1334 DVT (DEEP VENOUS THROMBOSIS).
|
|---|
| 182 | 1335 PERSISTENT NEUROLOGICAL WORSENING OVER 4 DAYS POST-OP.........
|
|---|
| 183 | 58 49. REASON FOR NO SURGERY.........
|
|---|
| 184 | 50. RADIATION THERAPY.............: None
|
|---|
| 185 | 51. DATE RADIATION STARTED........:
|
|---|
| 186 | 52. DATE RADIATION ENDED..........: 00/00/0000
|
|---|
| 187 | 53. TOTAL RADIATION DOSE (cGy)....: No radiation administered
|
|---|
| 188 | 54. NUMBER OF TREATMENTS TO THIS VOLUME.......................:
|
|---|
| 189 | 55. TYPE OF EXT BEAM RADIATION....: No radiation therapy
|
|---|
| 190 | 56. INTERSTITIAL RAD/BRACHYTHERAPY: None, brachytherapy not given
|
|---|
| 191 | 57. STEREOTACTIC RADIOSURGERY.....: None, not administered
|
|---|
| 192 | 58. RADIATION/SURGERY SEQUENCE....:
|
|---|
| 193 | 59. RADIATION COMPLICATIONS:
|
|---|
| 194 | SKIN REACTIONS...............: NA, radiation tx not administered
|
|---|
| 195 | ANOREXIA.....................: NA, radiation tx not administered
|
|---|
| 196 | NAUSEA OR VOMITING...........: NA, radiation tx not administered
|
|---|
| 197 | FATIGUE......................: NA, radiation tx not administered
|
|---|
| 198 | NEUROLOGIC WORSENING.........: NA, radiation tx not administered
|
|---|
| 199 | 50. RADIATION THERAPY.............: Unk, death cert cases only
|
|---|
| 200 | 52. DATE RADIATION ENDED..........: 99/99/9999
|
|---|
| 201 | 53. TOTAL RADIATION DOSE (cGy)....: Dose unknown
|
|---|
| 202 | 55. TYPE OF EXT BEAM RADIATION....: Unknown
|
|---|
| 203 | 56. INTERSTITIAL RAD/BRACHYTHERAPY: Unknown
|
|---|
| 204 | 57. STEREOTACTIC RADIOSURGERY.....: Unknown
|
|---|
| 205 | SKIN REACTIONS...............: Unknown
|
|---|
| 206 | NAUSEA OR VOMITING...........: Unknown
|
|---|
| 207 | NEUROLOGIC WORSENING.........: Unknown
|
|---|
| 208 | 1345 50. RADIATION THERAPY.............
|
|---|
| 209 | 361 52. DATE RADIATION ENDED..........
|
|---|
| 210 | 1336 53. TOTAL RADIATION DOSE (cGy)....
|
|---|
| 211 | 56 54. NUMBER OF TREATMENTS TO THIS VOLUME......................
|
|---|
| 212 | 1337 55. TYPE OF EXT BEAM RADIATION....
|
|---|
| 213 | 1338 56. INTERSTITIAL RAD/BRACHYTHERAPY
|
|---|
| 214 | 1339 57. STEREOTACTIC RADIOSURGERY.....
|
|---|
| 215 | 51.3 58. RADIATION/SURGERY SEQUENCE....
|
|---|
| 216 | 1340 SKIN REACTIONS...............
|
|---|
| 217 | 1342 NAUSEA OR VOMITING...........
|
|---|
| 218 | 1344 NEUROLOGIC WORSENING.........
|
|---|
| 219 | 75 60. REASON FOR NO RADIATION.......
|
|---|
| 220 | 61. DATE CHEMOTHERAPY STARTED.....:
|
|---|
| 221 | 63. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED:
|
|---|
| 222 | PROCARBAZINE.................: NA, chemotherapy not administered
|
|---|
| 223 | CCNU.........................: NA, chemotherapy not administered
|
|---|
| 224 | VINCRISTINE..................: NA, chemotherapy not administered
|
|---|
| 225 | HYDROXYUREA..................: NA, chemotherapy not administered
|
|---|
| 226 | METHOTREXATE.................: NA, chemotherapy not administered
|
|---|
| 227 | CISPLATIN....................: NA, chemotherapy not administered
|
|---|
| 228 | BCNU.........................: NA, chemotherapy not administered
|
|---|
| 229 | BCNU WAFER IMPLANT...........: NA, chemotherapy not administered
|
|---|
| 230 | VP-16........................: NA, chemotherapy not administered
|
|---|
| 231 | CARBOPLATIN..................: NA, chemotherapy not administered
|
|---|
| 232 | TEMOZOLOMIDE.................: NA, chemotherapy not administered
|
|---|
| 233 | CYCLOPHOSPHAMIDE.............: NA, chemotherapy not administered
|
|---|
| 234 | CPT-11.......................: NA, chemotherapy not administered
|
|---|
| 235 | TAMOXIFEN....................: NA, chemotherapy not administered
|
|---|
| 236 | INTERFERON...................: NA, chemotherapy not administered
|
|---|
| 237 | CYTARABINE (ARA-C)...........: NA, chemotherapy not administered
|
|---|
| 238 | OTHER........................: NA, chemotherapy not administered
|
|---|
| 239 | BCNU WAFER IMPLANT...........: Unknown
|
|---|
| 240 | 1351 BCNU WAFER IMPLANT...........
|
|---|
| 241 | 64. CHEMOTHERAPEUTIC ROUTE........: NA, chemotherapy not administered
|
|---|
| 242 | 64. CHEMOTHERAPEUTIC ROUTE........: Unknown
|
|---|
| 243 | 1358 64. CHEMOTHERAPEUTIC ROUTE........
|
|---|
| 244 | 65. CHEMOTHERAPY COMPLICATIONS:
|
|---|
| 245 | HEARING LOSS.................: NA, chemotherapy not administered
|
|---|
| 246 | INFECTION....................: NA, chemotherapy not administered
|
|---|
| 247 | NAUSEA AND VOMITING REQUIRING CESSATION OF CHEMOTHERAPY....: NA, chemotherapy not administered
|
|---|
| 248 | PERIPHERAL BLOOD COUNT DROP/ BLEEDING/CESSATION OF CHEMO- THERAPY AND/OR TRANSFUSION.: NA, chemotherapy not administered
|
|---|
| 249 | PERIPHERAL NEUROPATHY........: NA, chemotherapy not administered
|
|---|
| 250 | RENAL FAILURE................: NA, chemotherapy not administered
|
|---|
| 251 | PULMONARY TOXICITY...........: NA, chemotherapy not administered
|
|---|
| 252 | HEARING LOSS.................: Unknown
|
|---|
| 253 | PERIPHERAL NEUROPATHY........: Unknown
|
|---|
| 254 | RENAL FAILURE................: Unknown
|
|---|
| 255 | PULMONARY TOXICITY...........: Unknown
|
|---|
| 256 | 1359 HEARING LOSS.................
|
|---|
| 257 | 1361 NAUSEA AND VOMITING REQUIRING CESSATION OF CHEMOTHERAPY...
|
|---|
| 258 | 1362 PERIPHERAL BLOOD COUNT DROP/ BLEEDING/CESSATION OF CHEMO- THERAPY AND/OR TRANSFUSION.
|
|---|
| 259 | 1363 PERIPHERAL NEUROPATHY........
|
|---|
| 260 | 1364 RENAL FAILURE................
|
|---|
| 261 | 1365 PULMONARY TOXICITY...........
|
|---|
| 262 | 76 66. REASON FOR NO CHEMOTHERAPY....
|
|---|
| 263 | 67. DATE OTHER TREATMENT STARTED..:
|
|---|
| 264 | 68. OTHER TREATMENT...............:
|
|---|
| 265 | 1367 69. KARNOFSKY'S RATING AT TIME OF DISCHARGE/TRANSFER...........
|
|---|
| 266 | 70. DATE OF FIRST RECURRENCE
|
|---|
| 267 | 71. TYPE OF FIRST RECURRENCE
|
|---|
| 268 | 72. DATE OF PROGRESSION
|
|---|
| 269 | 73. TYPE OF PROGRESSION
|
|---|
| 270 | 74. RECURRENCE/PROGRESSION DOCUMENTATION
|
|---|
| 271 | 75. KARNOFSKY'S RATING AT TIME OF RECURRENCE/PROGRESSION
|
|---|
| 272 | 70. TYPE OF FIRST RECURRENCE
|
|---|
| 273 | 71. DATE OF FIRST RECURRENCE
|
|---|
| 274 | 70 70. DATE OF FIRST RECURRENCE......
|
|---|
| 275 | 1372 71. TYPE OF FIRST RECURRENCE......
|
|---|
| 276 | 1368 72. DATE OF PROGRESSION...........
|
|---|
| 277 | 1369 73. TYPE OF PROGRESSION...........
|
|---|
| 278 | 74. RECURRENCE/PROGRESSION DOCUMENTATION................: No recurrence/progession
|
|---|
| 279 | 1370 74. RECURRENCE/PROGRESSION DOCUMENTATION................
|
|---|
| 280 | 75. KARNOFSKY'S RATING AT TIME OF RECURRENCE/PROGRESSION.......: 888
|
|---|
| 281 | 1371 75. KARNOFSKY'S RATING AT TIME OF RECURRENCE/PROGRESSION.......
|
|---|
| 282 | 76. DATE OF SUBSEQUENT TREATMENT FOR RECURRENCE/PROGRESSION
|
|---|
| 283 | 77. PROTOCOL PARTICIPATION (SUBSEQUENT TREATMENT)
|
|---|
| 284 | 78. TYPE OF SUBSEQUENT SURGICAL TREATMENT FOR RECURRENCE/PROGRESSION
|
|---|
| 285 | 79. TYPE OF SUBSEQUENT RADIATION TREATMENT FOR RECURRENCE/PROGRESSION
|
|---|
| 286 | 80. TYPE OF SUBSEQUENT CHEMOTHERAPY FOR RECURRENCE/PROGRESSION
|
|---|
| 287 | 81. OTHER TYPE OF SUBSEQUENT TREATMENT FOR RECURRENCE/PROGRESSION
|
|---|
| 288 | SUBSEQUENT TREATMENT
|
|---|
| 289 | 76. DATE OF SUBSEQUENT TREATMENT FOR RECURRENCE/PROGRESSION...:
|
|---|
| 290 | 77. PROTOCOL PARTICIPATION (SUBSEQUENT TREATMENT).......: Not on
|
|---|
| 291 | 1373 77. PROTOCOL PARTICIPATION (SUBSEQUENT TREATMENT).......
|
|---|
| 292 | 78. TYPE OF SUBSEQUENT SURGICAL TX FOR RECURRENCE/PROGRESSION...: None, no subsequent surgery
|
|---|
| 293 | 1374 78. TYPE OF SUBSEQUENT SURGICAL TX FOR RECURRENCE/PROGRESSION...
|
|---|
| 294 | 79. TYPE OF SUBSEQUENT RADIATION TX FOR RECURRENCE/PROGRESSION...: None
|
|---|
| 295 | 1375 79. TYPE OF SUBSEQUENT RADIAITON TX FOR RECURRENCE/PROGRESSION...
|
|---|
| 296 | 80. TYPE OF SUBSEQUENT CHEMOTHERAPY FOR RECURRENCE/PROGRESSION:
|
|---|
| 297 | Chemotherapy not administered
|
|---|
| 298 | PROCARBAZINE.......: NA CARBOPLATIN........: NA
|
|---|
| 299 | CCNU...............: NA TEMOZOLOMIDE.......: NA
|
|---|
| 300 | VINCRISTINE........: NA CYCLOPHOSPHAMIDE...: NA
|
|---|
| 301 | HYDROXYUREA........: NA CPT-11.............: NA
|
|---|
| 302 | METHOTREXATE.......: NA TAMOXIFEN..........: NA
|
|---|
| 303 | #################### #################### ####################
|
|---|
| 304 | #################### #################### ####################
|
|---|
| 305 | #################### #################### ####################
|
|---|
| 306 | #################### #################### ####################
|
|---|
| 307 | #################### #################### ####################
|
|---|
